Saeed Ahmed, MD
Saeed Ahmed, MD, is an Addiction Psychiatrist, serves as the Medical Director of West Ridge Center at Rutland Regional Medical Center, Vermont. After graduating from Sindh Medical College Karachi, Pakistan, he completed Adult Psychiatry residency at Nassau University Medical Center, East Meadow, New York, followed by the Addiction Psychiatry fellowship at the Boston University Medical Center/ VA Boston Healthcare System.
During his residency, Dr. Ahmed served as a Chief Resident as well as on various committees of the residency program. He has been actively involved with the American Psychiatric Association (APA) in various capacities including APA diversity leadership fellow and a fellow member at the APA Council on Addiction Psychiatry. He is also a member of the membership committee of the American Academy of Addiction Psychiatry (AAAP). Being a former AADPRT Nyapati Rao/Francis Lu International Medical Graduate (IMG) Fellow, Dr. Ahmed has a distinct interest in mentoring IMGs, who seek residency/fellowship training in the United States. He currently provides addiction treatment services at West Ridge Recover clinic as well as to the inpatient psychiatry unit for people with and without co-occurring disorders.
In addition to his clinical work, his research focus is on substance use disorders, specifically, micro-induction of Buprenorphine / Naloxone, investigating off-label medications “repurposing” in substance use disorders, increasing access to and reducing barriers to the utilization of available treatments for substance use disorders.
Anika Alvanzo, MD, MS, FASAM, FACP
Anika Alvanzo, MD, MS, FASAM, FACP is an Assistant Professor in the Division of General Internal Medicine at Johns Hopkins University School of Medicine. Dr. Alvanzo is a graduate of the George Washington University School of Medicine and Health Sciences and holds a master’s degree in biostatistics from Virginia Commonwealth University. She is board certified in Internal Medicine and is a Diplomate of the American Board of Addiction Medicine. Dr Alvanzo is a Fellow of ASAM, the Region V Director for the ASAM Board of Directors and the Immediate Past President of the Maryland-DC Society of Addiction Medicine (MDDCSAM).
At Johns Hopkins, Dr. Alvanzo is currently the Associate Medical Director at Addiction Treatment Services and the Center for Addiction and Pregnancy where she oversees the medical care of patients in these two comprehensive, outpatient substance use disorder treatment programs. Dr. Alvanzo is also the Director of the Addiction Medicine Rotation for the Johns Hopkins Medicine-Pediatrics Urban Health and Urban Health Primary Care Internal Medicine Residency track programs. Her research interests include gender and race/ethnicity differences in the risk for substance use disorders and the association between psychological trauma, posttraumatic stress, and substance use, particularly in women. Dr. Alvanzo has served as an expert on National Institutes of Health (NIH) and Substance Abuse and Mental Health Services Administration (SAMHSA) panels on the role of opioids in chronic pain and integration of recovery-oriented care in hospital and medical settings, respectively. Most recently Dr. Alvanzo was an invited rapporteur and panelist at the National Academies of Sciences, Engineering and Medicine, “Workshop on Integrating Infectious Disease Considerations with Response to the Opioid Epidemic”.
Caridad C. Ponce Martinez, MD
I am currently an Assistant Professor in Psychiatry at the UMass School of Medicine, as well as an Assistant Professor Adjunct in the Department of Psychiatry at the Yale School of Medicine. I am double board certified in Psychiatry and in Addiction Psychiatry. I earned my undergraduate degree in Psychology at Tufts University and completed medical school at the Escuela Autónoma de Ciencias Médicas de Centro América in Costa Rica. I completed my adult psychiatry residency training at the University of Virginia, where I served as a Chief Resident and had an integral role in the evaluation of the Psychiatry residency program and its academic curriculum, particularly as related to substance use disorders. I then completed fellowship training in Addiction Psychiatry at Yale University. My clinical and research interests include expanding access to treatment for substance use disorders in a variety of clinical settings. In my role as medical director on an inpatient psychiatric unit, I have developed and implemented a protocol for treatment of opioid use disorder in the UMass inpatient psychiatric units. I am also currently conducting a study that evaluates the outcomes of initiating medication assisted treatment for patients with opioid use disorder during an acute inpatient psychiatric hospitalization. Additionally, I am the Addiction Psychiatry consultant at a local substance use disorder residential program for Latino men. As a result of my work there, I have become interested in exploring how the provision of culturally appropriate care for minority and underrepresented communities may improve outcomes. I have authored several articles in peer-reviewed journals and five book chapters, including one in the 10th edition of Kaplan & Sadock’s Comprehensive Textbook of Psychiatry.
Hector Colon-Rivera, MD
Dr. Colon-Rivera grew up between San Juan and Vieques, Puerto Rico. Following medical school in Puerto Rico and a residency in psychiatry at the Boston University Medical Center, he completed his addiction psychiatry training at Yale University. He is currently a faculty member at the University of Pennsylvania and the Philadelphia Veteran Affairs Medical Center where he specializes in the acute care of patients with a wide variety of mental health and substance use disorders. Alongside he is an attending physician at the University of Pittsburg Medical Center working on an emerging community program to increase rural access to Medical Assisted Treatments for patients with substance use disorder.
He has been committed to actively serving the American Psychiatric Association (APA) in leadership positions. He served at the Joint Reference Committee, the Board of Trustee, and the APA Council on Addiction Psychiatry. He is currently the president of the Hispanic Caucus and a consultant for the Council on Membership for the APA.
Dr. Colon-Rivera also serves as a clinical advisor for the Advisory on Alcohol and Other Drugs committee for the State of Pennsylvania, and he is the senior advisor for the Opioid State Targeted Response Technical Assistance for Puerto Rico.
Ricardo Cruz, MD
Dr. Ricardo Cruz is a primary care physician at Boston Medical Center in the Department of Medicine, Section of General Internal Medicine. He is a graduate of Boston University School of Medicine (BUSM) and the BUSM/Boston Medical Center (BMC) Internal Medicine Residency Primary Care Training Program. He is the Principal Investigator of the Department of Health and Human Services Office of Minority Health funded Project RECOVER (Referral, Engagement, Coaching, Overdose preVention Education in Recovery), a project that utilizes peer recovery coaches to assist with engagement and retention of individuals with opioid use disorder into treatment and primary care services after completion of acute treatment services (detoxification). In addition, he is a Clinician Educator and is part of the Core Faculty of the Internal Medicine Primary Care Training Program at BUSM/BMC. He is in the BUSM Academy of Medical Educators where he teaches medical students during the pre-clinical doctoring courses with a focus on development of clinical reasoning. He has been a co-investigator on NIAAA and NIDA-funded randomized clinical trials testing medications for alcohol and cocaine use disorders. His interests are in providing primary care and treatment for substance use disorders for vulnerable populations including racial and ethnic minority communities, specifically, Latinx and individuals with history of criminal justice involvement.
E. Jennifer Edelman, MD, MHS
Dr. Edelman is an Associate Professor at the Yale School of Medicine. Certified as an internist, HIV specialist and in Addiction Medicine, she serves as the physician consultant for the Addiction Treatment Program at the Yale-New Haven Hospital Nathan Smith HIV clinic. Over the past 10 years, her work has focused on addressing opioid and alcohol use to promote HIV prevention and treatment. This includes leading NIH-funded studies focused on understanding harms associated with opioid use among patients living with HIV and efforts to promote implementation of addiction treatment in clinical settings. She is Associate Director of the Research in Addiction Medicine Scholars (RAMS) Program. She has a BS from Cornell University, MD from Columbia University and MHS from Yale University.
Ellen Edens, MD, MPE, MA
Dr. Edens is an Assistant Professor of Psychiatry at Yale University School of Medicine. In 2002, Dr. Edens received her MD from the Johns Hopkins School of Medicine and completed psychiatry residency training and graduate work in psychiatric epidemiology at Washington University in St. Louis. She is board-certified in addiction psychiatry following advanced training in Addiction Psychiatry at Yale University School of Medicine, where she joined the faculty in 2011. Dr. Edens is the Associate Director of the Addiction Psychiatry Residency at Yale, an ACGME-accredited program, overseeing the program’s didactic curriculum and clinical supervision. She serves as co-director of the VA Interprofessional Advanced Fellowship in Addiction Treatment. Her clinical and research interests dovetail in the areas of co-occurring addiction and chronic pain and expansion of access to evidence-based treatments for addiction, particularly opioid and alcohol use disorders. She is the clinical co-director of the VA Opioid Reassessment Clinic, a clinic designed to assess the safety, efficacy, and misuse of opioids by Veterans treated with prescription opioids for chronic pain. Additionally, she is actively working on developing and disseminating interprofessional educational material on the topic of addiction screening, diagnosis, and initiation of substance use treatment.
David A. Fiellin, MD
David A. Fiellin, MD, is a Professor of Medicine, Emergency Medicine and Public Health at Yale. He Directs the Yale Program in Addiction Medicine and the Clinical and Health Services Research Core at Yale’s Center for Interdisciplinary Research on AIDS. He is board certified in Internal Medicine and Addiction Medicine. His NIH-funded research is on the interface between substance use and general medical settings including office-based practice, primary care, Emergency Department and HIV specialty settings. He has received awards from the American Association for the Treatment of Opioid Dependence, the American Society of Addiction Medicine, AMERSA, and the Hazelden Betty Ford Foundation. He is Co-Editor of the ASAM textbook, Principles of Addiction Medicine, 4th, 5th and 6th Editions, and on the Editorial Boards of 4 addiction specialty journals. He has served on the Board of Directors of the College on Problems of Drug Dependence and as Co-Chair of the Substance Abuse Interest Group at the Society of General Internal Medicine.
Holly Hagle, PhD
Holly Hagle, PhD, is a Program Director/Assistant Research Professor in the Collaborative to Advance Health Services, at the University of Missouri-Kansas City’s School of Nursing and Health Studies. She is the Co-Director of the National Addiction Technology Transfer Center (ATTC) Network Coordinating Office (NCO) and Principal Investigator (PI) for the Prevention Technology Transfer Center (PTTC) NCO. In addition, she is the UMKC PI and Co-Director on behalf of the ATTC Network for the Opioid State Targeted Response Technical Assistance (STR-TA) grant. Dr. Hagle has been actively working with medical and behavioral health providers for more than 15 years on the integration of behavioral health interventions.
Lamia Haque, MD, MPH
Lamia Haque completed her medical training at the Alpert Medical School of Brown University and a masters in public health at the Mailman School of Public Health at Columbia University. She completed her internal medicine training in the Yale Primary Care Residency Program followed by the Yale Addiction Medicine Fellowship. She is now a fellow in the Yale Digestive Diseases Section with a scholarly focus on epidemiology and treatment of substance use disorders in patients with chronic hepatitis C infection and cirrhosis.
Brady Heward, MD
Brady Heward, MD, attended medical school at Yale University School of Medicine. After completing medical school, he participated in a general psychiatry internship and residency at Yale. During residency he took advantage of the diverse clinical opportunities working at a community mental health center, a private hospital and at the VA. In addition he spent time researching how culture can impact parental behaviors and definitions of childhood maltreatment. Following residency, Dr. Heward participated in a public psychiatry fellowship at Yale working at the Connecticut Mental Health Center primarily working on the inpatient unit. He subsequently left Connecticut to complete a child and adolescent fellowship in Vermont. Dr. Heward is currently back at Yale completing an addiction fellowship and hopes to further work with diverse and underserved adolescents and young adults with co-occurring disorders.
Stephen R. Holt, MD, MS, FACP
Dr. Holt attended Columbia University’s College of Physicians & Surgeons, and subsequently completed his residency and Chief Residency at Yale School of Medicine’s Primary Care Internal Medicine Residency Program before joining the faculty. He has served as the Associate Program Director of Yale’s Primary Care Program since 2010. His areas of interest include addiction medicine, medical education, and the art and science of physical diagnosis. He is board-certified in both Internal Medicine and Addiction Medicine.
Current clinical activities include ambulatory clinic precepting, co-directing Yale’s Addiction Recovery Clinic, and general medicine ward attending several months per year. He is the director of Musculoskeletal Education and Addiction Medicine Education within the Primary Care training program, and codirects the Clinician Educator Distinction Track within the Department of Medicine. He has won numerous teaching awards at Yale and nationally, including the Faculty Teacher of the Year Award (Yale Primary Care Residency, 2009 and 2017), the Leonard Tow Humanism in Medicine Award (Yale School of Medicine, 2014), and the New Investigator/Educator Award (Association for Medical Education and Research in Substance Abuse,2016) and gives recurring lectures on physical diagnosis, medical education, and addiction medicine topics both at Yale and nationally. Dr. Holt has authored numerous articles, reviews, and book chapters on addiction medicine topics and is a premier author for Yale’s Office-based Medicine Curriculum, used by over 200 residency programs nationally.
Outside of the hospital, Dr. Holt is an avid guitarist and naturalist who genuinely enjoys the art and science of tree identification. He lives in Connecticut with his wife and their two daughters (9 and 10 years old) that entertain him nightly.”
Theddeus Iheanacho, MD
Dr. Theddeus Iheanacho, MD, is an Assistant Professor of Psychiatry at Yale University School of Medicine and the Medical Director of Errera Community Care Center, VA Connecticut Healthcare System. He is board certified in general psychiatry and addiction psychiatry. In addition to teaching and clinical work, he has research interest in substance use disorders, specifically, increasing access to and reducing barriers to the utilization of medication assisted treatment for substance use disorders in the homeless population. Dr. Iheanacho completed medical school in Nigeria and psychiatric training in Dublin, Ireland and the United States.
Anna Lembke, MD
Anna Lembke, MD, is an associate professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She is medical director of Stanford Addiction Medicine, program director for the Stanford Addiction Medicine Fellowship, and chief of the Stanford Addiction Medicine Dual Diagnosis Clinic. Dr. Lembke received her BA in Humanities from Yale University and her MD from Stanford University, where she also completed her residency in Psychiatry and fellowship in mood disorders. She is a diplomate of the American Board of Psychiatry and Neurology, and of the American Board of Addiction Medicine. Dr. Lembke has developed multiple teaching programs on drug misuse and addiction therapy. She has held multiple leadership and mentorship positions and received the Stanford’s Chairman’s Award for Clinical Innovation, and the Stanford Departmental Award for Outstanding Teaching. She chaired the Planning Committee for the California Society of Addiction Medicine (CSAM) Annual Addiction Medicine Conference and was the president of the Addiction Medicine Fellowship Directors Association (AMFDA). She is the author of the bestselling book, “Drug Dealer, MD: How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop” (Johns Hopkins University Press, November 2016).
Carla Marienfeld, MD
Carla Marienfeld, MD, is a board-certified addiction psychiatrist at the University of California, San Diego who supports recovery in a harm-reduction approach through therapy, motivational interviewing, and medication treatment. An associate clinical professor of psychiatry, her research looks at health outcomes for individuals with substance use disorders, and she published a book Motivational Interviewing for Clinical Practice. She has been highly involved in education of colleagues and trainees about addiction psychiatry and effective interventions including buprenorphine treatment and motivational interviewing, and she is the fellowship director for the UCSD Addiction Psychiatry Fellowship. Dr. Marienfeld completed a fellowship in addiction psychiatry and residency training in psychiatry at Yale. During her residency, she was chief resident of psychiatry and founded (and later led) the Yale Global Mental Health Program as junior faculty at Yale. She earned a medical degree with honors from Baylor College of Medicine in Houston.
Myra L. Mathis-Uwanogho, MD
Myra L. Mathis-Uwanogho, MD is a Senior Instructor and Attending Psychiatrist at the University of Rochester Department of Psychiatry in the Division of Community Psychiatry. She is a graduate of the University of Rochester School of Medicine and Dentistry and trained in General Adult and Addiction Psychiatry at Yale University School of Medicine. During training Dr. Mathis-Uwanogho served in dual chief positions as the Program-Wide and Medical Education Chief Resident and developed the Rebellious Psychiatry Conference, the first trainee-led event examining the intersection of mental health and social justice. She has worked in private, state and federal healthcare systems, providing psychiatric and substance use treatment to adolescent, adult, and geriatric populations. Dr. Mathis-Uwanogho currently treats patients at Strong Recovery, an outpatient dual-diagnosis clinic which houses an Opioid Treatment Program and provides a full range of addiction and psychiatric services. Her academic interests include health equity and racial justice, particularly as it relates to psychiatric and addiction treatment, psychotherapy and psychopharmacology for the treatment of substance use disorders, and medical education.
Kenneth Morford, MD
Dr. Morford is an Addiction Medicine Fellow and Postdoctoral Associate at Yale School of Medicine. He completed his residency in the Yale Primary Care Internal Medicine Program and served as Chief Resident for the VA Connecticut Healthcare System Center of Excellence in Primary Care Education. He currently provides primary care and addiction treatment services at the APT Foundation, which is a large, non-profit addiction recovery center focused on open access and harm reduction. He is a scholar in the Research in Addiction Medicine Scholars (RAMS) Program funded by the National Institute on Drug Abuse (NIDA) and studies the effects of benzodiazepine use in patients with opioid use disorder. He also works on two studies focused on integrating addiction treatment in HIV clinics. He is a clinical coach for medical and nurse practitioner students, faculty advisor for the Yale Addiction Medicine Collaborative, and teaches workshops related to addiction, chronic pain, motivational interviewing, and primary care.
Srinivas Muvvala, MD, MPH
Dr. Muvvala is an assistant professor of psychiatry at the Yale School of Medicine and the medical director of the Substance Abuse Treatment Unit (SATU) at the Connecticut Mental Health Center (CMHC). He oversees the clinical and research programs at SATU and is involved in medical student, residency and fellowship education. His clinical and research interests are in investigating and disseminating optimal pharmacotherapies for the treatment of opioid, tobacco and alcohol use disorders and in providing comprehensive treatment for individuals with comorbid addictive and psychiatric disorders.
Shadi Nahvi, MD, MS
Dr. Shadi Nahvi is an Associate Professor in the Departments of Medicine and Psychiatry and Behavioral Sciences at the Albert Einstein College of Medicine, and Co- Director of the General Internal Medicine and Addiction Medicine Fellowship Programs. Her research focuses on optimizing quality of life and health outcomes among persons with substance use disorder.
Dr. Nahvi’s research is grounded in over a decade of clinical experience as a primary care physician caring for persons with opioid and other substance use disorders. Her primary research focus is optimizing the efficacy and delivery of tobacco cessation treatments among persons with co-occurring substance use disorders. Currently, she is Principal Investigator of a NIDA R01-funded randomized, 2 x 2 factorial trial of directly observed and long-term varenicline treatment among smokers with opioid use disorder. She has also led a KL2 Career Development Award-funded, randomized, placebo- controlled pilot trial of varenicline for smoking cessation among smokers with co-morbid substance use disorder, a study of health system-level interventions to increase documentation and treatment of tobacco use among substance use disorder counselors, and a randomized trial of the efficacy of directly observed varenicline provided at a methadone clinic for promoting smoking cessation and enhancing adherence.
Dr. Nahvi graduated from the Brown University School of Medicine in 2001 and completed residency training in Primary Care Internal Medicine at Bellevue Hospital and New York University Medical Center in 2004.
Austin Nation, PhD, RN, PHN
Austin Nation, PhD, RN, PHN is a graduate of the University of California, San Francisco – School of Nursing, Community Health Systems. He has been a nurse for over 35 years and is currently an Assistant Professor in the School of Nursing at California State University (CSU), Fullerton.
Dr. Nation completed both the Minority Training Program in Cancer Control Research (MTPCCR), as well as was awarded the California Pre-doctoral Program – Sally Casanova Pre-doctoral Scholars, completing summer research internships at both Yale University and Duke University.
Dr. Nation was also a fellow in the Black AIDS Institute’s African American HIV University – Science and Treatment College and was the recipient of the CSU Chancellor/William Randolph Hearst Award and the Graduate Assistant in Areas of National Need (GAANN) – Clinical Teaching and Research Scholar Fellow.
He is actively involved in a number of professional organizations including Western Institute of Nursing, the Association of Nurses in AIDS Care and National Black Nurses Association.
He has been doing HIV prevention education for over 20 years. His past research interest was with understanding substance use and HIV among young Black men who have sex with men (MSM), funded by the Substance Abuse Mental Health Services Administration (SAMHSA)/ American Nurses Association (ANA) Minority Fellowship Program. He is currently exploring LGBTQ+ health care and mental health care access in Orange County.
Patrick G. O’Connor, MD, MPH, FACP
Dr. Patrick O’Connor is a Dan Adams and Amanda Adams Professor of General Medicine and Chief of General Internal Medicine at Yale University School of Medicine and Yale New Haven Hospital in New Haven, Connecticut. Dr. O’Connor came to Yale as a fellow in the Robert Wood Johnson Clinical Scholars Program during which time he also received a M.P.H. from the Yale School of Public Health. As Chief of General Internal Medicine at Yale he led several new initiatives in patient care, education, and research and has overseen a 3-fold expansion in the size of the faculty and 10-fold increase in research funding. Dr. O’Connor’s research has focused on the interface between primary care and addiction medicine. Specific topics within his research area have included: 1) the integration of primary care and substance use disorder treatment services, 2) strategies for primary care-based opioid detoxification and opioid maintenance for the treatment of opioid use disorder, 3) strategies for managing unhealthy alcohol use and alcohol use disorder in primary care settings, 4) medical education about addiction, and 5) addiction health policy. He served as an author on Facing Addiction in America. The Surgeon General’s Report on Alcohol, Drugs, and Health. He has also collaborated with federal agencies such as The White House Office on Drug Control Policy and with addiction-focused organizations in academia and the private sector. Dr. O’Connor is Past President of the American Board of Addiction Medicine (ABAM) and the Addiction Medicine Foundation (TAMF), Past President of the Association for Medical Research and Education in Substance Abuse (AMERSA) and is a member of the new Addiction Medicine Sub-board and Examination Committee for the American Board of Preventive Medicine. As Chief of the Section of General Internal Medicine at Yale he was recognized with his receipt of the first annual Chief’s Recognition Award from the Society of General Internal Medicine (SGIM) and the Association of Chiefs of General Internal Medicine (ACGIM). He received both the Mentorship and the McGovern Award from AMERSA.
Alexander Y. Walley, MD, MSc
Dr. Walley is an Associate Professor of Medicine at Boston University School of Medicine and a general internist and addiction medicine specialist at Boston Medical Center. He has been the director of the Boston Medical Center Addiction Medicine Fellowship program since 2011. His research focus is on the medical complications of substance use, specifically HIV and overdose. He provides primary care and office-based addiction treatment for patients with HIV at Boston Medical Center and on the inpatient Addiction Consult Service, which he founded in 2015. He is the medical director for the Massachusetts Department of Public Health’s Opioid Overdose Prevention Pilot Program. Since 2007, the MDPH program has trained over 80,000 people in Massachusetts’s communities, including people who use opioids, people in recovery, and their social networks. He graduated from Harvard College, received his MD from Johns Hopkins School of Medicine and Masters of Science in epidemiology from Boston University School of Public Health.
Melissa B. Weimer, DO, MCR
Melissa Weimer is board certified in general internal medicine and addiction medicine. She became the Medical Director of the Yale Addiction Medicine Consult Service and Assistant Professor of Medicine at Yale School of Medicine in 2018. Prior to serving in this role she worked as the Chief of Behavioral Health and Addiction Medicine at St. Peter’s Health Partners in Albany, NY and as Assistant Professor of Medicine in the Division of Internal Medicine at Oregon Health & Science University in Portland, OR. Dr. Weimer’s career has focused on treating patients who struggle with concomitant chronic pain and substance use disorders, expanding access and expertise around medication treatments for substance use disorders, and creating access to substance use disorder care for hospitalized patients. Dr. Weimer is an experienced educator in helping providers understand substance use disorders, how to address concomitant pain and substance use disorder, and how to safely and effectively prescribe opioids in the outpatient and inpatient setting.